ADAPTIMMUNE THERAPTCS (ADAPY) Revenue by Year

ADAPY

ADAPTIMMUNE THERAPTCS generated $178.0M in revenue in fiscal year 2024. This represents an increase of 195.3% from the prior fiscal year. Over the trailing 12 months, Q3 FY2024 through Q2 FY2025, the same line adds up to $65.1M in revenue. The table below carries 12 fiscal years, from 2013 to 2024, and the quarters ADAPTIMMUNE THERAPTCS has filed alongside them.

FY2024 annual

Revenue $178.0M

YoY +195.3%

5Y CAGR +175.5%

10Y CAGR +71.2%

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2025, ended Jun 30, 2025 Reported Aug 13, 2025 Currency USD

Annual figures, oldest first. Point at a bar to read its period.

ADAPY Revenue by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

Metric	TTM	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K
Revenue	$65.1M	$178.0M+195.3%	$60.3M+122.0%	$27.1M+341.5%	$6.1M+55.4%	$4.0M+252.8%	$1.1M-98.1%	$59.5M+57.3%	$37.8M+166.5%	$14.2M+43.8%	$9.9M+1096.5%	$825K	N/A

TTM is the trailing twelve months, Q3 FY2024 through Q2 FY2025, summed from the four most recent quarterly filings.

ADAPY Revenue by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

Metric	Q2'2510-Q	Q1'2510-Q	Q4'2410-Q	Q3'2410-Q	Q2'2410-Q	Q1'2410-Q	Q4'2310-K	Q3'2310-Q	Q2'2310-Q	Q1'2310-Q	Q4'2210-K	Q3'2210-Q
Revenue	$13.7M-89.3%	$7.3M+28.3%	$3.2M+1294.8%	$40.9M+458.8%	$128.2M+2399.6%	$5.7M-88.1%	$231K-97.9%	$7.3M+4.5%	$5.1M-7.4%	$47.6M+1231.5%	$11.0M+678.3%	$7.0M+482.5%

What revenue means

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.

More ADAPTIMMUNE THERAPTCS financials

Frequently Asked Questions

What was ADAPTIMMUNE THERAPTCS's revenue in fiscal year 2024?

ADAPTIMMUNE THERAPTCS generated $178.0M in revenue in fiscal year 2024.

How fast is ADAPTIMMUNE THERAPTCS's revenue growing?

ADAPTIMMUNE THERAPTCS (ADAPY) revenue rose by 195.3% year over year, from $60.3M to $178.0M in fiscal year 2024.

What is ADAPTIMMUNE THERAPTCS's revenue over the last twelve months?

ADAPTIMMUNE THERAPTCS (ADAPY) reported $65.1M in revenue over the trailing 12 months, Q3 FY2024 through Q2 FY2025, summed from the four most recent quarterly filings.

What was ADAPTIMMUNE THERAPTCS's revenue in the most recent quarter?

ADAPTIMMUNE THERAPTCS (ADAPY) reported $13.7M in revenue in Q2 2025. This represents a decrease of 89.3% from the same quarter a year earlier.

What does revenue mean on a financial statement?

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what ADAPTIMMUNE THERAPTCS (ADAPY) reported on that line in every period on record.